Literature DB >> 6156980

Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. V. Role of idiotypes in the suppressor pathway.

J Z Weinberger, R N Germain, B Benacerraf, M E Dorf.   

Abstract

4-Hydroxy-3-nitrophenyl (NP) derivatized syngeneic spleen cells injected intravenously stimulate maturation of an antigen-binding, idiotype-bearing induction-phase suppressor cell population, as well as an idiotype-binding anti-idiotype-bearing effector-phase suppressor cell population. Both cell types are present simultaneously in the spleen cell population 7-d after their induction. Furthermore, the cell population with antigen-binding properties can, in the presence of NP-derivatized syngeneic cells, induce a population of effector suppressor cells. The precursors of the effector suppressor population are not sensitive to concentrations of cyclophosphamide which prevented the generation of induction phase suppressor cells. These data provide direct evidence in support of the theory of network regulation of immune suppression. X

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156980      PMCID: PMC2185900          DOI: 10.1084/jem.152.1.161

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Soluble factors in tolerance and contact sensitivity to DNFB in mice. II. Genetic requirements for suppression of contact sensitivity by soluble suppressor factor.

Authors:  J W Moorhead
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

2.  Idiotype suppression. III. Induction of unresponsiveness to sensitization with anti-idiotypic antibody: identification of the cell types tolerized in high zone and in low zone, suppressor cell-mediated, idiotype suppression.

Authors:  D Hetzelberger; K Eichmann
Journal:  Eur J Immunol       Date:  1978-12       Impact factor: 5.532

3.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

4.  Production of large amounts of antibodies in individual mice.

Authors:  A S Tung; S T Ju; S Sato; A Nisonoff
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

5.  Enrichment of specific suppressor T cells and characterization of their surface markers.

Authors:  M Taniguchi; J F Miller
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

6.  Cellular basis of regulation of expression of idiotype. I. T-suppressor cells specific for MOPC 460 idiotype regulate the expression of cells secreting anti-TNP antibodies bearing 460 idiotype.

Authors:  C Bona; W E Paul
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

7.  Shared idiotypic determinants on antibodies and T-cell-derived suppressor factor specific for the random terpolymer L-glutamic acid60-L-alanine30-L-tyrosine10.

Authors:  R N Germain; S T Ju; T J Kipps; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

8.  Anti-idiotype induced regulation of helper cell function for the response to phosphorylcholine in adult BALB/c mice.

Authors:  K Bottomly; B J Mathieson; D E Mosier
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

9.  Presence on idiotype-specific suppressor T cells of receptors that interact with molecules bearing the idiotype.

Authors:  F L Owen; S T Ju; A Nisonoff
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

10.  Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition.

Authors:  D D Eardley; J Hugenberger; L McVay-Boudreau; F W Shen; R K Gershon; H Cantor
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  36 in total

1.  Activation of peripheral blood T cells via the p75 interleukin 2 receptor.

Authors:  H Yagita; M Nakata; A Azuma; T Nitta; T Takeshita; K Sugamura; K Okumura
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

2.  Non-specific inhibitor made by T acceptor cells inhibits both the afferent and efferent stage of the contact sensitivity reaction.

Authors:  M A Zembala; V Colizzi; G L Asherson; M C Watkins
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

Review 3.  Structure of antigen-specific suppressor factors: current views.

Authors:  S K Kontiainen; R F James; E J Culbert; M Feldmann
Journal:  Surv Immunol Res       Date:  1982

4.  Tolerance and immunity in mice infected with herpes simplex virus: studies on the mechanism of tolerance to delayed-type hypersensitivity.

Authors:  A A Nash; J Phelan; P G Gell; P Wildy
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

5.  B-lymphocyte responses to trinitrophenyl-conjugated Ficoll: requirement for T lymphocytes and Ia-bearing adherent cells.

Authors:  N L Letvin; B Benacerraf; R N Germain
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

6.  Independent regulation of serologically distinct idiotypes in F1 hybrid mice.

Authors:  T F Kresina; M J Nelles; A Nisonoff; A R Brown
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

7.  Antigen- and receptor-driven regulatory mechanisms. VII. H-2-restricted anti-idiotypic suppressor factor from efferent suppressor T cells.

Authors:  M H Dietz; M S Sy; B Benacerraf; A Nisonoff; M I Greene; R N Germain
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

8.  Regulation of immunoglobulin E antibody synthesis in man by antiidiotypic antibodies.

Authors:  R S Geha; M Comunale
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

9.  Functional association of idiotypic and I-J determinants on the antigen receptor of suppressor T cells.

Authors:  K Okuda; M Minami; S T Ju; M E Dorf
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

10.  Inheritance patterns of idiotype expression: maternal-fetal immune regulatory networks.

Authors:  J C Olson; G A Leslie
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.